Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase

Pharm Biotechnol. 1998:11:393-422. doi: 10.1007/0-306-47384-4_17.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Azasteroids / pharmacokinetics
  • Azasteroids / pharmacology*
  • Cholestenone 5 alpha-Reductase
  • Dihydrotestosterone / metabolism
  • Dose-Response Relationship, Drug
  • Dutasteride
  • Enzyme Inhibitors / pharmacology*
  • Finasteride / pharmacology
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Oxidoreductases / antagonists & inhibitors*
  • Oxidoreductases / physiology

Substances

  • Azasteroids
  • Enzyme Inhibitors
  • Isoenzymes
  • Dihydrotestosterone
  • Finasteride
  • Oxidoreductases
  • Cholestenone 5 alpha-Reductase
  • Dutasteride